Financials Garofalo Health Care S.p.A.

Equities

GHC

IT0005345233

Healthcare Facilities & Services

Real-time Borsa Italiana 05:50:55 2024-02-21 am EST 5-day change 1st Jan Change
4.84 EUR +0.41% Intraday chart for Garofalo Health Care S.p.A. -0.41% +4.31%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 300.1 471.5 433.4 491.1 327.4 426.9 426.9 -
Enterprise Value (EV) 1 252.8 566.2 531.1 633.5 472.4 563.9 530.9 495.9
P/E ratio 21.5 x 36 x 37.9 x 26.2 x 15.3 x 18.3 x 16.8 x 16 x
Yield - - - - - - - -
Capitalization / Revenue 1.93 x 2.4 x 2.06 x 1.73 x 1.01 x 1.2 x 1.14 x 1.12 x
EV / Revenue 1.62 x 2.88 x 2.52 x 2.23 x 1.46 x 1.58 x 1.42 x 1.3 x
EV / EBITDA 8.48 x 14.8 x 15.6 x 11.9 x 8.06 x 8.42 x 7.48 x 6.79 x
EV / FCF 27 x -4.72 x 123 x 54.4 x 16.3 x 21.9 x 16.1 x 13.9 x
FCF Yield 3.71% -21.2% 0.81% 1.84% 6.12% 4.57% 6.2% 7.22%
Price to Book 1.68 x 3.33 x 2.34 x 1.88 x 1.17 x 1.42 x 1.34 x 1.24 x
Nbr of stocks (in thousands) 82,000 81,859 81,773 89,298 88,966 88,578 88,578 -
Reference price 2 3.660 5.760 5.300 5.500 3.680 4.820 4.820 4.820
Announcement Date 4/18/19 3/23/20 3/16/21 3/16/22 3/16/23 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net sales 1 155.6 196.5 210.8 283.7 322.6 356 374 381
EBITDA 1 29.8 38.2 34 53.1 58.6 67 71 73
EBIT 1 23.59 24 15.49 28.23 31.66 42 45 46
Operating Margin 15.16% 12.21% 7.35% 9.95% 9.82% 11.8% 12.03% 12.07%
Earnings before Tax (EBT) 1 18.03 18.66 13.02 23.99 27.37 32 35 37
Net income 1 13.58 13.14 11.78 18.83 21.43 23 26 27
Net margin 8.73% 6.69% 5.59% 6.64% 6.64% 6.46% 6.95% 7.09%
EPS 2 0.1700 0.1600 0.1400 0.2100 0.2400 0.2640 0.2870 0.3020
Free Cash Flow 1 9.377 -120 4.315 11.65 28.9 25.8 32.9 35.8
FCF margin 6.02% -61.07% 2.05% 4.11% 8.96% 7.25% 8.8% 9.4%
FCF Conversion (EBITDA) 31.47% - 12.69% 21.93% 49.32% 38.51% 46.34% 49.04%
FCF Conversion (Net income) 69.03% - 36.63% 61.83% 134.89% 112.17% 126.54% 132.59%
Dividend per Share - - - - - - - -
Announcement Date 4/18/19 3/23/20 3/16/21 3/16/22 3/16/23 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2019 S1 2020 S1 2021 Q2 2021 S1 2021 Q3 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 S1 2023 Q3
Net sales 1 92.86 89.9 73.09 133.5 64.38 80.41 85.88 166.3 70.28 86 92.28 94.38 186.7 76.47
EBITDA 1 17.38 8.747 14.15 24.74 7.72 14.33 16.84 31.17 11.15 16.28 18.76 19.49 38.25 12.72
EBIT 1 13.05 3.272 - - 2.2 7.845 11.86 19.71 5.553 6.717 13.96 12.04 26.01 6.129
Operating Margin 14.06% 3.64% - - 3.42% 9.76% 13.82% 11.85% 7.9% 7.81% 15.13% 12.76% 13.93% 8.02%
Earnings before Tax (EBT) - - - - - - - - - - - - - -
Net income - 1.249 5.485 9.769 - - - - - - - - - -
Net margin - 1.39% 7.5% 7.32% - - - - - - - - - -
EPS - 0.0200 - - - - - - - - - - - -
Dividend per Share - - - - - - - - - - - - - -
Announcement Date 9/26/19 9/23/20 9/13/21 9/13/21 11/14/22 5/13/22 9/12/22 9/12/22 11/14/22 3/16/23 5/15/23 9/12/23 9/12/23 11/14/23
1EUR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net Debt 1 - 94.7 97.7 142 145 137 104 69
Net Cash position 1 47.3 - - - - - - -
Leverage (Debt/EBITDA) - 2.478 x 2.873 x 2.681 x 2.475 x 2.045 x 1.465 x 0.9452 x
Free Cash Flow 1 9.38 -120 4.32 11.6 28.9 25.8 32.9 35.8
ROE (net income / shareholders' equity) 9.91% 6.96% 5.96% 8.13% 7.94% - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 2.180 1.730 2.260 2.920 3.140 3.400 3.600 3.900
Cash Flow per Share - - - 0.4100 0.4900 - - -
Capex 1 9.14 8.81 - 24.7 15 17.8 14.9 15.2
Capex / Sales 5.87% 4.48% - 8.7% 4.64% 5% 3.98% 3.99%
Announcement Date 4/18/19 3/23/20 3/16/21 3/16/22 3/16/23 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
4.82 EUR
Average target price
6 EUR
Spread / Average Target
+24.48%
Consensus

Quarterly revenue - Rate of surprise

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019
Replicate our performance
fermer